Results 11 to 20 of about 2,335,195 (317)
What is resistant arterial hypertension?
Blood Pressure, 2023 Purpose The current review is to describe the definition and prevalence of resistant arterial hypertension (RAH), the difference between refractory hypertension, patient characteristics and major risk factors for RAH, how RAH is diagnosed, prognosis and ...Evgeniya V. Shalaeva, Franz H. Messerlidoaj +2 more sourcesCatheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension
HYPERTENSION, 2023 Background: Recent sham-controlled randomized clinical trials have confirmed the safety and efficacy of catheter-based renal denervation (RDN). Long-term safety and efficacy data beyond 3 years are scarce.Gianni Sesa-Ashton, J. Nolde, Ida Muente, R. Carnagarin, Rebecca Lee, V. Macefield, T. Dawood, Y. Sata, Elisabeth Lambert, G. Lambert, A. Walton, M. G. Kiuchi, M. Esler, M. Schlaich +13 moresemanticscholar +1 more sourcePhase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
New England Journal of Medicine, 2022 BACKGROUND
Aldosterone synthase controls the synthesis of aldosterone and has been a pharmacologic target for the treatment of hypertension for several decades.M. Freeman, Y. Halvorsen, W. Marshall, Mackenzie Pater, J. Isaacsohn, Catherine Pearce, Brian Murphy, N. Alp, Ajay Srivastava, Deepak L. Bhatt, Morris J. Brown +10 moresemanticscholar +1 more sourceDual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
The Lancet, 2022 BACKGROUND
Resistant hypertension is associated with increased cardiovascular risk. The endothelin pathway has been implicated in the pathogenesis of hypertension, but it is currently not targeted therapeutically, thereby leaving this relevant ...M. Schlaich, M. Bellet, Michael A. Weber, P. Danaietash, G. Bakris, J. Flack, R. F. Dreier, Mouna Sassi-sayadi, L. Haskell, K. Narkiewicz, Ji-Guang Wang, C. Reid, M. Schlaich, I. Katz, A. Ajani, S. Biswas, M. Esler, G. Elder, S. Roger, D. Colquhoun, J. Mooney, T. Backer, A. Persu, M. Chaumont, J. Krzesinski, Thomas Vanabsche, G. Girard, L. Pliamm, Ernesto Schiffrin, F. Merali, G. Dresser, M. Vallée, Shivinder Jolly, S. Chow, Ji-Gwang Wang, J. Mu, Jing Yu, Hong Yuan, Ying-qing Feng, Xin Zhang, Jianhong Xie, Ling Lin, M. Soucek, J. Widimský, R. Cífková, J. Václavík, Martin Ullrych, M. Lukac, I. Rychlík, T. G. Lauridsen, I. Kantola, J. Taurio, O. Ukkola, O. Ormezzano, P. Gosse, M. Azizi, P. Courand, P. Delsart, J. Tartière, F. Mahfoud, R. Schmieder, J. Stegbauer, Philipp C. Lurz, M. Koziolek, C. Ott, Nicole Toursarkissian, K. Tsioufis, K. Kyfnidis, A. Manolis, S. Patsilinakos, P. Zebekakis, A. Karavidas, Páll Dénes, Katalin Bezzegh, Marianna Zsom, L. Kovács, Y. Sharabi, M. Elias, Ivetta Sukholutsky, C. Yosefy, I. Kenis, S. Atar, M. Volpe, Muiesan Maria Lorenza, S. Taddei, G. Grassi, F. Veglio, J. Son, Jang-Young Kim, Joong-il Park, Chang Hoon Lee, Hae-Young Lee, R. Raugaliene, J. Marcinkeviciene, R. Kavaliauskiene, J. Deinum, A. Kroon, B. Born, A. Januszewicz, A. Tykarski, J. Walczewska, Z. Gaciong, A. Więcek, M. Chrostowska, A. Kleinrok, J. Krekora, G. Kania, Anna Podrazka-Szczepaniak, Cezary Goławski, Maciej Podziewski, B. Kaczmarek, G. Skoczylas, A. Wilkołaski, I. Woźniak, Marzena Janik-Palazzolo, B. Rewerska, A. Konradi, Yu. V. Shvarts, T. Pecherina, K. Nikolaev, Gapon Liudmila, O. Orlikova, V. Mordovin, N. Petrochenkova, G. Kamalov, E. Kosmacheva, Vadim V Tyrenko, V. Gorbunov, A. Obrezan, T. Supryadkina, I. Ler, O. Kotenko, A. Kuzin, F. Martinez, J. Redón, A. Oliveras, Luis Beltran Romero, Valerii Shatylo, L. Rudenko, Andriiy Bazylevych, Yu.Yu. Rudyk, O. Karpenko, M. Stanislavchuk, V. Tseluyko, M. Kushnir, E. Asanov, Y. Sirenko, A. Yagensky, D. Collier, Pankaj Gupta, David Webb, M. MacLeod, James McLay, A. Peace, S. Arora, Patricia Buchanan, Robert Harris, R. Degarmo, Mario Guillen, Adam D Karns, J. Neutel, Y. Paliwal, Karl Pettis, P. Toth, Jeffrey Wayne, B. Butcher, P. Diller, S. Oparil, D. Calhoun, D. Brautigam, J. Flack, Jesse Goldman, A. Rashidi, N. Aslam, William Haley, N. Andrawis, B. Lang, Randy L. Miller, J. Powell, R. Dewhurst, J. Pritchard, D. Khanna, Dennis M. Tang, Nashwa Gabra, Jean-Ho Park, Conigliaro Jones, C. Scott, B. Luna, Murtaza Mussaji, R. Bhagwat, M. Bauer, J. McGinty, R. Nambiar, R. Sangrigoli, W. R. Davis, Will Eaves, F. Mcgrew, Ahmed K. Awad, E.J. Bolster, D. Scott, Paramjit Kalirao, Pascal Dabel, Wesley Calhoun, S. Gouge, Mark Warren, M. K. Lawrence, A. Jamal, M. El-Shahawy, C. Mercado, J. Kumar, P. Velásquez-Mieyer, R. Busch, T. Lewis, L. Rich +213 moresemanticscholar +1 more sourceResistant hypertension: consensus document from the Korean society of hypertension
Clinical Hypertension, 2023 Although reports vary, the prevalence of true resistant hypertension and apparent treatment-resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively.Sungha Park, Jinho Shin, S. Ihm, Kwang-il Kim, Hack-Lyoung Kim, Hyeon-Chang Kim, E. Lee, J. Lee, Shin Young Ahn, Eun Joo Cho, Ju Han Kim, Hee-Taik Kang, Hae-Young Lee, Sunki Lee, Woo-Shik Kim, Jong-Moo Park +15 moresemanticscholar +1 more sourceApparent treatment-resistant hypertension among ambulatory hypertensive patients: a cross-sectional study from 13 general hospitals [PDF]
The Korean Journal of Internal Medicine, 2021 Background/Aims To examine the prevalence and clinical characteristics of apparent treatment-resistant hypertension among ambulatory hypertensive patients.Sehun Kim, Jin Joo Park, Mi-Seung Shin, Choong Hwan Kwak, Bong-Ryeol Lee, Sung-Ji Park, Hae-Young Lee, Sang-Hyun Kim, Seok-Min Kang, Byung-Su Yoo, Joong-Wha Chung, Si Wan Choi, Sang-Ho Jo, Jinho Shin, Dong-Ju Choi +14 moredoaj +1 more sourceCatheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
Hypertension Research, 2021 Renal denervation is a promising new non-pharmacological treatment for resistant hypertension. However, there is a lack of data from Asian patients.K. Kario, Y. Yokoi, K. Okamura, M. Fujihara, Yukako Ogoyama, E. Yamamoto, H. Urata, Jin-man Cho, C. Kim, Seung‐Hyuk Choi, Keisuke Shinohara, Y. Mukai, Tomokazu Ikemoto, Masato Nakamura, S. Seki, S. Matoba, Yoshisato Shibata, S. Sugawara, K. Yumoto, K. Tamura, F. Yoshihara, Satoko Nakamura, W. Kang, Taro Shibasaki, K. Dote, H. Yokoi, A. Matsuo, H. Fujita, Toshiyuki Takahashi, H. Kang, Y. Sakata, K. Horie, N. Inoue, Ken-ichiro Sasaki, T. Ueno, H. Tomita, Y. Morino, Y. Nojima, Chan Joon Kim, Tomoaki Matsumoto, H. Kai, S. Nanto +41 moresemanticscholar +1 more sourceEffects of Lifestyle Modification on Patients With Resistant Hypertension
Circulation, 2021 Supplemental Digital Content is available in the text. Background: Although lifestyle modifications generally are effective in lowering blood pressure (BP) among patients with unmedicated hypertension and in those treated with 1 or 2 antihypertensive ...J. Blumenthal, A. Hinderliter, Patrick J. Smith, Stephanie Mabe, L. Watkins, L. Craighead, Krista Ingle, Crystal C Tyson, P. Lin, W. Kraus, L. Liao, A. Sherwood +11 moresemanticscholar +1 more sourceResistant hypertension [PDF]
Heart, 2011 See related article, pp 1076–1080 Resistant hypertension (RHTN) is most simply defined as high blood pressure (BP) requiring ≥4 antihypertensive medications, whether controlled or uncontrolled.1 The true prevalence of RHNT is unknown and is likely to remain so, because determining an accurate estimation of prevalence would require a large prospective ...Mustafa I. Ahmed, David A. Calhounopenaire +3 more sources
